New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer
Authors:
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 18 (8) , 971-976
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation for Distinguished Young Scholars of China (81625016)
- National Natural Science Foundation of China (81372649, 81172276, 81370065, 81372653)
- Shanghai Natural Science Foundation (17ZR1406300)
- Science and Technology Commission of Shanghai Municipality (15JC1401200)
This publication has 27 references indexed in Scilit:
- Clinical Significance and Revisiting the Meaning of CA 19-9 Blood Level Before and After the Treatment of Pancreatic Ductal Adenocarcinoma: Analysis of 1,446 Patients from the Pancreatic Cancer Cohort in a Single InstitutionPLOS ONE, 2013
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative TherapyAnnals of Surgical Oncology, 2012
- The prognostic and predictive value of serum CA19.9 in pancreatic cancerAnnals of Oncology, 2012
- Serum CA19–9 Alterations During Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Invasive Ductal Carcinoma of the Pancreas as an Indicator for Therapeutic Selection and SurvivalAnnals of Surgery, 2010
- Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant ChemoradiationAnnals of Surgical Oncology, 2010
- Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704Journal of Clinical Oncology, 2008
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2004
- Influence of Lewis α1-3/4-L-Fucosyltransferase (FUT3) Gene Mutations on Enzyme Activity, Erythrocyte Phenotyping, and Circulating Tumor Marker Sialyl-Lewis a LevelsJournal of Biological Chemistry, 1996
- Lewis Phenotype of Erythrocytes and Leb‐Active Glycolipid in Serum of Pregnant Women1Vox Sanguinis, 1981